Trials / Unknown
UnknownNCT04775615
Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Healthy Subjects.
A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multi-dose DDO-3055 Tablets in Healthy Subjects-Randomized, Double-blind, Dose Escalation, Placebo Controlled Phase I Clinical Trial.
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The study is being conducted to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multi-dose DDO-3055 tablets in healthy subjects for 7 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DDO-3055 tablets；Placebo | Low dose：DDO-3055 tablets for 7 days or Placebo for 7 days |
| DRUG | DDO-3055 tablets；Placebo | Medium dose：DDO-3055 tablets for 7 days or Placebo for 7 days |
| DRUG | DDO-3055 tablets；Placebo | High dose：DDO-3055 tablets for 7 days or Placebo for 7 days |
Timeline
- Start date
- 2021-03-17
- Primary completion
- 2021-05-31
- Completion
- 2021-06-01
- First posted
- 2021-03-01
- Last updated
- 2021-03-01
Source: ClinicalTrials.gov record NCT04775615. Inclusion in this directory is not an endorsement.